Supplementary Figure S8. STLMS genomic risk stratification for progression-free survival (PFS). A, A 2-tier genomic risk group is proposed for PFS. PFS for 151 patients with primary STLMS from the MSK cohort with low- and high-risk genomic groups is represented by Kaplan-Meier curves.
No takes yet. Share an insight, caveat, or question.
Dermawan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: